Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.
Bile duct cancer
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Survival
Texture
Journal
Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931
Informations de publication
Date de publication:
03 Jul 2020
03 Jul 2020
Historique:
received:
11
02
2020
accepted:
29
06
2020
entrez:
5
7
2020
pubmed:
6
7
2020
medline:
3
11
2020
Statut:
epublish
Résumé
To assess the performance of imaging features, including radiomics texture features, in predicting histopathologic tumor grade, AJCC stage, and outcomes [time to recurrence (TTR) and overall survival (OS)] in patients with intrahepatic cholangiocarcinoma (ICC). Seventy-three patients (26 M/47F, mean age 63y) with pre-operative imaging (CT, n = 37; MRI, n = 21; CT and MRI, n = 15] within 6 months of resection were included in this retrospective study. Qualitative imaging traits were assessed by 2 observers. A 3rd observer measured tumor apparent diffusion coefficient (ADC), enhancement ratios (ERs), and Haralick texture features. Blood biomarkers and imaging features were compared with histopathology (tumor grade and AJCC stage) and outcomes (TTR and OS) using log-rank, generalized Wilcoxon, Cox proportional hazards regression, and Fisher exact tests. Median TTR and OS were 53.9 and 79.7 months. ICC recurred in 64.4% (47/73) of patients and 46.6% (34/73) of patients died. There was fair accuracy for some qualitative imaging features in the prediction of worse tumor grade (maximal AUC of 0.68 for biliary obstruction on MRI, p = 0.032, observer 1) and higher AJCC stage (maximal AUC of 0.73 for biliary obstruction on CT, p = 0.002, observer 2; and AUC of 0.73 for vascular involvement on MRI, p = 0.01, observer 2). Cox proportional hazards regression analysis showed that CA 19-9 [hazard ratio (HR) 2.44/95% confidence interval (CI) 1.31-4.57/p = 0.005)] and tumor size on imaging (HR 1.13/95% CI 1.04-1.22/p = 0.003) were significant predictors of TTR, while CA 19-9 (HR 4.08/95% CI 1.75-9.56, p = 0.001) and presence of metastatic lymph nodes at histopathology (HR 2.86/95% CI 1.35-6.07/p = 0.006) were significant predictors of OS. On multivariable analysis, satellite lesions on CT (HR 2.79/95%CI 1.01-7.15/p = 0.032, observer 2), vascular involvement on MRI (HR 0.10/95% CI 0.01-0.85/p = 0.032, observer 1), and texture feature MRI variance (HR 0.55/95% CI 0.31-0.97, p = 0.040) predicted TTR once adjusted for the independent predictors CA 19-9 and tumor size on imaging. Several qualitative and quantitative features demonstrated associations with TTR, OS, and AJCC stage at univariable analysis (range: HR 0.35-19; p < 0.001-0.045), however none were predictive of OS at multivariable analysis when adjusted for CA 19-9 and metastatic lymph nodes (p > 0.088). There was reasonable accuracy in predicting tumor grade and higher AJCC stage in ICC utilizing certain qualitative and quantitative imaging traits. Serum CA 19-9, tumor size, presence of metastatic lymph nodes, and qualitative imaging traits of satellite lesions and vascular involvement are predictors of patient outcomes, along with a promising predictive ability of certain quantitative texture features.
Sections du résumé
BACKGROUND
BACKGROUND
To assess the performance of imaging features, including radiomics texture features, in predicting histopathologic tumor grade, AJCC stage, and outcomes [time to recurrence (TTR) and overall survival (OS)] in patients with intrahepatic cholangiocarcinoma (ICC).
METHODS
METHODS
Seventy-three patients (26 M/47F, mean age 63y) with pre-operative imaging (CT, n = 37; MRI, n = 21; CT and MRI, n = 15] within 6 months of resection were included in this retrospective study. Qualitative imaging traits were assessed by 2 observers. A 3rd observer measured tumor apparent diffusion coefficient (ADC), enhancement ratios (ERs), and Haralick texture features. Blood biomarkers and imaging features were compared with histopathology (tumor grade and AJCC stage) and outcomes (TTR and OS) using log-rank, generalized Wilcoxon, Cox proportional hazards regression, and Fisher exact tests.
RESULTS
RESULTS
Median TTR and OS were 53.9 and 79.7 months. ICC recurred in 64.4% (47/73) of patients and 46.6% (34/73) of patients died. There was fair accuracy for some qualitative imaging features in the prediction of worse tumor grade (maximal AUC of 0.68 for biliary obstruction on MRI, p = 0.032, observer 1) and higher AJCC stage (maximal AUC of 0.73 for biliary obstruction on CT, p = 0.002, observer 2; and AUC of 0.73 for vascular involvement on MRI, p = 0.01, observer 2). Cox proportional hazards regression analysis showed that CA 19-9 [hazard ratio (HR) 2.44/95% confidence interval (CI) 1.31-4.57/p = 0.005)] and tumor size on imaging (HR 1.13/95% CI 1.04-1.22/p = 0.003) were significant predictors of TTR, while CA 19-9 (HR 4.08/95% CI 1.75-9.56, p = 0.001) and presence of metastatic lymph nodes at histopathology (HR 2.86/95% CI 1.35-6.07/p = 0.006) were significant predictors of OS. On multivariable analysis, satellite lesions on CT (HR 2.79/95%CI 1.01-7.15/p = 0.032, observer 2), vascular involvement on MRI (HR 0.10/95% CI 0.01-0.85/p = 0.032, observer 1), and texture feature MRI variance (HR 0.55/95% CI 0.31-0.97, p = 0.040) predicted TTR once adjusted for the independent predictors CA 19-9 and tumor size on imaging. Several qualitative and quantitative features demonstrated associations with TTR, OS, and AJCC stage at univariable analysis (range: HR 0.35-19; p < 0.001-0.045), however none were predictive of OS at multivariable analysis when adjusted for CA 19-9 and metastatic lymph nodes (p > 0.088).
CONCLUSIONS
CONCLUSIONS
There was reasonable accuracy in predicting tumor grade and higher AJCC stage in ICC utilizing certain qualitative and quantitative imaging traits. Serum CA 19-9, tumor size, presence of metastatic lymph nodes, and qualitative imaging traits of satellite lesions and vascular involvement are predictors of patient outcomes, along with a promising predictive ability of certain quantitative texture features.
Identifiants
pubmed: 32620153
doi: 10.1186/s40644-020-00323-0
pii: 10.1186/s40644-020-00323-0
pmc: PMC7333305
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
43Références
Radiographics. 2009 May-Jun;29(3):683-700
pubmed: 19448110
Radiology. 2011 Jul;260(1):148-57
pubmed: 21474703
Hepatology. 2001 Jun;33(6):1353-7
pubmed: 11391522
Surgery. 2013 Jun;153(6):811-8
pubmed: 23499016
J Hepatol. 2004 Mar;40(3):472-7
pubmed: 15123362
Am J Surg. 2002 Jun;183(6):679-85
pubmed: 12095601
Sci Rep. 2017 May 26;7(1):2452
pubmed: 28550313
J Am Coll Surg. 2016 Sep;223(3):493-505.e2
pubmed: 27296525
Eur Radiol. 2018 May;28(5):2047-2057
pubmed: 29234913
Radiology. 2006 Jan;238(1):150-5
pubmed: 16304089
Radiology. 2016 Nov;281(2):382-391
pubmed: 27144536
Radiology. 2009 Feb;250(2):444-52
pubmed: 19164695
J Hepatol. 2002 Dec;37(6):806-13
pubmed: 12445422
Nucl Med Mol Imaging. 2017 Mar;51(1):69-78
pubmed: 28250860
Acad Radiol. 2006 Jun;13(6):713-20
pubmed: 16679273
J Magn Reson Imaging. 2017 May;45(5):1476-1484
pubmed: 27626270
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
AJR Am J Roentgenol. 2017 Aug;209(2):W64-W75
pubmed: 28570102
Eur J Radiol. 2015 Aug;84(8):1444-1451
pubmed: 26022518
Hepatobiliary Surg Nutr. 2017 Feb;6(1):35-43
pubmed: 28261593
Medicine (Baltimore). 2017 Aug;96(34):e7891
pubmed: 28834905
Arch Pathol Lab Med. 2010 Apr;134(4):e14-8
pubmed: 20367294
Abdom Radiol (NY). 2018 Oct;43(10):2665-2672
pubmed: 29492607
HPB (Oxford). 2015 Apr;17(4):344-51
pubmed: 25395176
Acad Radiol. 2019 Sep;26(9):1164-1173
pubmed: 30425000
Med Phys. 2017 Mar;44(3):1050-1062
pubmed: 28112418
PLoS One. 2015 Jul 24;10(7):e0132953
pubmed: 26207380
Radiology. 2016 Oct;281(1):119-28
pubmed: 27115053
Eur Radiol. 2015 Oct;25(10):2840-50
pubmed: 25991476
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6265-73
pubmed: 26578786
HPB (Oxford). 2015 Mar;17(3):244-50
pubmed: 25410716
Sci Rep. 2017 Oct 4;7(1):12689
pubmed: 28978930
Clin Radiol. 2014 Dec;69(12):e463-70
pubmed: 25240565
JAMA Surg. 2014 Jun;149(6):565-74
pubmed: 24718873
Surgery. 2008 Mar;143(3):366-74
pubmed: 18291258
JAMA Surg. 2014 May;149(5):432-8
pubmed: 24599477
Eur Radiol. 2017 Feb;27(2):498-506
pubmed: 27165138
Radiology. 2019 Mar;290(3):691-699
pubmed: 30620253
Magn Reson Imaging Clin N Am. 2010 Aug;18(3):383-402, ix
pubmed: 21094446
Acad Radiol. 2007 Dec;14(12):1520-30
pubmed: 18035281
Oncologist. 2016 May;21(5):594-9
pubmed: 27000463